Follow ASTCT®
Tandem Meetings News
-
Mortimer M. Bortin Lecturer to share how teamwork has advanced field
Stella Davies, MBBS, PhD, MRCP, tells how collaboration has elevated bone marrow transplant outcomes in children and adults.
-
Experts discuss potential developments and challenges in gene therapies
Panelists, including Julie Kanter, MD, point to examples of gene editing advancements, savvy intellectual property plans and teamwork.
-
Plenary session tracks the leading edge of cellular therapy in solid tumors and autoimmune disease
Experts discuss the potential impact of innovative engineered immune cells and other emerging approaches.
-
Session panelists review current practices and future directions in allogeneic donor selection
Experts consider how the advent of post-transplant cyclophosphamide (PTCy) has driven guideline changes and opened new possibilities.
-
Robert S. Negrin, MD | ASTCT Lifetime Achievement Award
Robert S. Negrin, MD, the 2026 ASTCT Lifetime Achievement Award winner, shares how his groundbreaking work has been guided by thinking deeply about the questions we address and the ways we pursue them.
-
Danielle Kirkey, MD | New Investigator Award (NIA)
NIA recipient Danielle Kirkey, MD, talks about her research goals to change the landscape of immunotherapy in acute myeloid leukemia (AML).
-
Stosh Ozog, MD, PhD | New Investigator Award (NIA)
NIA recipient Stosh Ozog, MD, PhD, discusses his goal of characterizing T cell dynamics following hematopoietic cell transplantation.
-
Sunmin Park, MD, PhD | New Investigator Award (NIA)
NIA recipient Sunmin Park, MD, PhD, details the work behind a project focused on developing a novel cellular therapy for GVHD.
-
Session to look at heterogeneity of hematopoietic stem cells behind cell therapy
Chair Christopher Hourigan, DM, DPhil, FRCP, discusses the potential for better understanding the diversity of cells that make HSC transplant successful.
-
Joint plenary session marks successes and challenges of cell therapy landscape
Speakers highlight real-world success in increasing treatments and note possible solutions for obstacles ahead.